Copy

This week's grand rounds

April 13 @ 8:00-9:00 am

No Time to Lose: What Have We Learned from Ebola, AIDS and Zika Epidemics?

Peter Piot is the Director of the School and a Professor of Global Health. He is the Chair of the MRC Global Health Group and a member of the MRC Strategy Board.

Our Latest News

Department of Medicine attains Portfolio Program Sponsor Status with ABMS

Physicians in the Department of Medicine will soon be able to receive ABMS Maintenance of Certification (MOC) credits for quality improvement (QI) activities right at Stanford.

State of the Department presentation set for April 25

Faculty, staff, researchers, and students are invited to join Department Chair Bob Harrington, MD, for his annual State of the Department presentation at 5 p.m. on April 25.

And one for the road: Why a single shot may not (always) be enough to stave off shingles

Many of ur-psychoanalyst Sigmund Freud‘s pet concepts have long since been debunked, and debunked again, under a steady onslaught of neuroscience and pharmacology.

Stanford Medicine’s popular Health Matters event returns to campus

On Saturday, May 14, Stanford Medicine will host its annual free community day at the Li Ka Shing Center for Learning and Knowledge.

Joy Wu discusses the Translational Investigator Program

The goal of Stanford’s Translational Investigator Program (TIP) is to provide unparalleled training and mentorship for individuals planning research-intensive careers.

Marlene Rabinovitch honored for lifetime of contributions

Marlene Rabinovitch, MD will give the 2016 J. Burns Amberson Lecture at the American Thoracic Society's annual meeting in San Francisco on May 15

New from the Stanford 25 blog: Spasticity versus rigidity

Can you differentiate between spasticity versus rigidity?

Watch Andrew Pipe’s Grand Rounds talk: “Citius, Altius, Fortius: Semper Vigilo! Doping in Sport.”

Presenter: Andrew Pipe, MD, Chief, Division of Prevention and Rehabilitation, University of Ottawa Heart Institute

Congratulations to the recipients of Stanford CVI’s Drug Discovery Conference research prizes

Upcoming Grand Rounds

April 20 @ 8:00-9:00 am

Precision Medicine: From Vision to Reality

April 27 @ 8:00-9:00 am

Going Viral with Zika

Department Events

April 11 @ 12:00-1:00 pm

Faculty Meeting

Department of Medicine

April 12 @ 8:00-9:00 am

Donor Derived Infections in the Setting of Organ Transplantation

ID Lecture Series

April 12 @ 8:00-9:00 am

Anal Cancer – New Terminology, New Staging, New Approaches to Prevention, Same Old Chemo radiation

Cancer Education Seminar

April 12 @ 12:00-1:00 pm

With Calum MacRae

Frontiers in Cardiovascular Science

April 12 @ 1:00-2:00 pm

Closing the Gap – Identifying TB Drug Targets at the Host-Pathogen Interface

ID Special Seminar

April 13 @ 1:00-2:00 pm

Case Discussions

PCCM Joint Chest Conference

April 13 @ 4:00-5:00 pm

The State of Vaccine Confidence – A Global Perspective

Research in Progress

April 14 @ 4:00-5:00 pm

Research in Epidemic Times – The Cases of Ebola and Zika

ID Grand Rounds

April 15 @ 7:00-8:00 am

Asthma

PCCM Core Lecture

April 15 @ 12:00-1:00 pm

T-NK Cells, IL-15, and EBV: A Lymphoma Ensemble

Special Oncology Seminar

TBA

Presented by Shravani Pasupneti, PCCM Fellow

PCCM Journal Club

April 15 @ 1:00-2:00 pm

With Shravani Pasupneti

PCCM Grand Rounds

Announcements »

In the News

“Obesity surgery linked to reduced pain, improved mobility” - A new study from the University of Pittsburgh suggests that obese patients have less pain and better mobility in the first few years after weight loss surgery. John Morton provides comment.

Fox News


“Phase 3 clinical trial drug, Baricitinib, of benefit to rheumatoid arthritis patients who failed at other treatments” - A new drug for rheumatoid arthritis reduced symptoms and improved functions in patients for whom other therapies have failed. Lead author Mark Genovese is quoted.

Rheumatoid Arthritis News


“Digital assistance may optimize treatment in Type 2 Diabetes with hypertension” - Digital health assistance appears to be successful in reducing blood pressure and cholesterol in patients with Type 2 diabetes. Study investigator Lars Osterberg is quoted.

Endocrinology Advisor


Connect With Us @StanfordDeptMed

View in browser | Contact Us | Unsubscribe